Lisa Furby practices in the area of intellectual property law, with an emphasis on patent litigation. She has experience in all phases of patent litigation, including discovery, fact and expert depositions and testimony, claim construction, summary judgment, and trial. Lisa also has represented clients before the International Trade Commission and the Patent Trial and Appeal Board. She represents clients in a broad range of industries including the automotive and pharmaceutical industries.
In 2016, Lisa was a member of the trial team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages for sales of sofosbuvir-based medicines, including Sovaldi and Harvoni, for its infringement of an Idenix patent related to the treatment of patients with hepatitis C virus (HCV) infection.
All or Nothing: Why the Supreme Court SAS Mandate Does not Eliminate the Shaw Safe Harbor, PTAB Litigation Blog
Patent Transfer to Native American Tribe Does Not Immunize Patents from Inter Partes Review, PTAB Litigation Blog
- Washington University in St. Louis (J.D. magna cum laude 2013; Order of the Coif); Southern Illinois University Carbondale (B.S. in Mechanical Engineering summa cum laude 2010)
- Illinois, U.S. Court of Appeals for the Federal Circuit, U.S. District Court for the Northern District of Illinois, and registered to practice before the U.S. Patent and Trademark Office